MarketCapExport financials
Helen of Troy Limited (HELE)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Helen of Troy Limited Balance Sheet 2026-2009 | HELE
Brief overview of Helen of Troy Limited's financial position
The balance sheet is assessed across five available annual reports spanning 2022 to 2026.
Assets finished at $2.1 billion versus $2.8 billion initially, losing -25.1%. The balance sheet contracted.
Funding shifted toward liabilities: they gained -11.9%, compared with -25.1% for assets.
The share of internal funding stands at 37.7% versus 47% initially, providing a reasonable foundation.
Net debt reached $744 million, equal to 0.93x of equity. The debt profile is moderately stretched.
Cash equals 0.9% of the balance sheet, compared with 1.2% five periods ago. This is the readily available cushion.
Retained earnings are $412.8 million versus $1 billion initially. The direction shows how results contributed to equity.
Conclusion
Helen of Troy Limited's financial structure calls for caution. Stronger equity, lower debt or restored liquidity would be needed to improve it.
Annual Balance Sheet Helen of Troy Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
744 M | 895 M | 649 M | 906 M | 784 M | 303 M | 315 M | 309 M | 269 M | 462 M | 33.8 M | 421 M | 416 M | 164 M | 159 M | 208 M | - | - |
Long Term Debt |
756 M | 908 M | 659 M | 928 M | 811 M | 342 M | 337 M | 319 M | 288 M | 461 M | 23.8 M | 411 M | 597 M | 155 M | 175 M | 178 M | - | - |
Long Term Debt Current |
7.04 M | 6.11 M | 8.26 M | 7.12 M | 5.76 M | 5.97 M | 3.64 M | 1.88 M | 1.88 M | 24.4 M | 23.8 M | 21.9 M | 96.9 M | 20 M | 3 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 403 M | 341 M | 310 M | 503 M | 671 M | 487 M | 651 M | 239 M | 260 M | 216 M | - | - |
Total Current Liabilities |
505 M | 466 M | 451 M | 412 M | 603 M | 615 M | 339 M | 312 M | 297 M | 289 M | 269 M | 262 M | 329 M | 309 M | 379 M | - | - | - |
Total Liabilities |
1.32 B | 1.45 B | 1.2 B | 1.42 B | 1.5 B | 1.02 B | 742 M | 653 M | 609 M | 792 M | 940 M | 749 M | 919 M | 547 M | 639 M | 555 M | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | -12.1 M | 5.07 M | - | - | - |
Retained Earnings |
413 M | 1.31 B | 1.28 B | 1.16 B | 1.02 B | 965 M | 898 M | 746 M | 780 M | 798 M | 729 M | 722 M | 729 M | 762 M | 648 M | 560 M | - | - |
Total Assets |
2.12 B | 3.13 B | 2.84 B | 2.91 B | 2.82 B | 2.26 B | 1.9 B | 1.65 B | 1.62 B | 1.81 B | 1.87 B | 1.65 B | 1.85 B | 1.47 B | 1.44 B | 1.24 B | 835 M | - |
Cash and Cash Equivalents |
18.9 M | 18.9 M | 18.5 M | 29.1 M | 33.4 M | 45.1 M | 24.5 M | 11.9 M | 20.7 M | 23.1 M | 226 M | 12.3 M | 70 M | 12.8 M | 21.8 M | 27.2 M | 110 M | 103 M |
Book Value |
798 M | 1.68 B | 1.64 B | 1.49 B | 1.33 B | 1.24 B | 1.16 B | 997 M | 1.01 B | 1.02 B | 930 M | 905 M | 930 M | 927 M | 797 M | 686 M | 835 M | - |
Total Shareholders Equity |
798 M | 1.68 B | 1.64 B | 1.49 B | 1.33 B | 1.24 B | 1.16 B | 997 M | 1.01 B | 1.02 B | 930 M | 905 M | 1.03 B | 927 M | 797 M | 686 M | 584 M | - |
All numbers in USD currency
Quarterly Balance Sheet Helen of Troy Limited
| 2027-Q1 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
691 M | 869 M | 871 M | 851 M | 869 M | 871 M | 851 M | 908 M | 725 M | 705 M | 741 M | 659 M | 729 M | 839 M | 831 M | 928 M | 1.06 B | 1.15 B | 1.09 B | 811 M | 446 M | 470 M | 509 M | 342 M | 438 M | 298 M | 323 M | 337 M | 242 M | 299 M | 319 M | 319 M | 338 M | 299 M | 298 M | 288 M | 405 M | 423 M | 433 M | 461 M | 540 M | 524 M | 563 M | 597 M | 451 M | 456 M | 415 M | 411 M | 93.8 M | 93.8 M | 93.8 M | 95.7 M | 114 M | 107 M | 165 M | 155 M | 175 M | 175 M | 175 M | 175 M | 175 M | 175 M | - | 178 M |
Total Liabilities |
1.24 B | 1.49 B | 1.48 B | 1.42 B | 1.49 B | 1.48 B | 1.42 B | 1.45 B | 1.34 B | 1.31 B | 1.27 B | 1.2 B | 1.37 B | 1.4 B | 1.36 B | 1.42 B | 1.67 B | 1.83 B | 1.79 B | 1.5 B | 1.13 B | 1.13 B | 1.15 B | 1.02 B | 1.1 B | 866 M | 754 M | 742 M | 629 M | 689 M | 667 M | 653 M | 692 M | 619 M | 579 M | 609 M | 790 M | 761 M | 750 M | 792 M | 909 M | 864 M | 885 M | 919 M | 815 M | 836 M | 755 M | 749 M | 905 M | 939 M | 708 M | 504 M | 549 M | 547 M | 516 M | 547 M | 644 M | 657 M | 606 M | 639 M | 537 M | 557 M | - | 555 M |
Retained Earnings |
449 M | 468 M | 552 M | 861 M | 468 M | 552 M | 861 M | 1.31 B | 1.26 B | 1.21 B | 1.19 B | 1.28 B | 1.24 B | 1.17 B | 1.19 B | 1.16 B | 1.13 B | 1.08 B | 1.05 B | 1.02 B | 1.05 B | 980 M | 929 M | 965 M | 943 M | 1.05 B | 958 M | 898 M | 901 M | 833 M | 787 M | 746 M | 781 M | 827 M | 783 M | 780 M | 755 M | 813 M | 804 M | 798 M | 762 M | 775 M | 747 M | 729 M | 766 M | 719 M | 742 M | 722 M | 681 M | 626 M | 607 M | 846 M | 836 M | 798 M | 775 M | 762 M | 730 M | 694 M | 671 M | 648 M | 619 M | 586 M | - | 560 M |
Total Assets |
2.08 B | 2.34 B | 2.41 B | 2.65 B | 2.34 B | 2.41 B | 2.65 B | 3.13 B | 2.97 B | 2.88 B | 2.82 B | 2.84 B | 2.95 B | 2.9 B | 2.87 B | 2.91 B | 3.13 B | 3.23 B | 3.14 B | 2.82 B | 2.49 B | 2.4 B | 2.35 B | 2.26 B | 2.31 B | 2.17 B | 1.98 B | 1.9 B | 1.79 B | 1.78 B | 1.7 B | 1.65 B | 1.73 B | 1.69 B | 1.6 B | 1.62 B | 1.77 B | 1.8 B | 1.77 B | 1.81 B | 1.89 B | 1.86 B | 1.84 B | 1.63 B | 1.78 B | 1.75 B | 1.69 B | 1.62 B | 1.76 B | 1.74 B | 1.49 B | 1.53 B | 1.56 B | 1.52 B | 1.46 B | 1.47 B | 1.53 B | 1.51 B | 1.43 B | 1.44 B | 1.3 B | 1.28 B | - | 1.24 B |
Cash and Cash Equivalents |
21.7 M | 27.1 M | 22.4 M | 22.7 M | 27.1 M | 22.4 M | 22.7 M | 18.9 M | 40.8 M | 20.1 M | 16.1 M | 18.5 M | 25.2 M | 24.2 M | 38.9 M | 29.1 M | 45.3 M | 39.6 M | 49.3 M | 33.4 M | 44.3 M | 31.8 M | 37.4 M | 45.1 M | 157 M | 148 M | 88.5 M | 24.5 M | 19.6 M | 17 M | 18.4 M | 11.9 M | 19.1 M | 19.9 M | 16.9 M | 20.7 M | 19.9 M | 14.1 M | 17.1 M | 23.8 M | 16.8 M | 25.8 M | 23.1 M | 227 M | 21.1 M | 19.4 M | 15.3 M | 15.3 M | 21.1 M | 24.7 M | 29.2 M | 70 M | 28.8 M | 10.1 M | 12.1 M | 12.8 M | 16.1 M | 21.8 M | 20.9 M | 21.8 M | 35.4 M | 25.1 M | 16 M | 27.2 M |
Book Value |
844 M | 852 M | 926 M | 1.23 B | 852 M | 926 M | 1.23 B | 1.68 B | 1.63 B | 1.57 B | 1.55 B | 1.64 B | 1.59 B | 1.5 B | 1.51 B | 1.49 B | 1.46 B | 1.4 B | 1.36 B | 1.33 B | 1.35 B | 1.27 B | 1.2 B | 1.24 B | 1.21 B | 1.31 B | 1.22 B | 1.16 B | 1.16 B | 1.09 B | 1.04 B | 997 M | 1.03 B | 1.08 B | 1.02 B | 1.01 B | 984 M | 1.04 B | 1.02 B | 1.02 B | 980 M | 992 M | 956 M | 713 M | 968 M | 911 M | 932 M | 873 M | 859 M | 802 M | 780 M | 1.03 B | 1.01 B | 971 M | 944 M | 927 M | 890 M | 852 M | 827 M | 797 M | 764 M | 726 M | - | 686 M |
Total Shareholders Equity |
844 M | 852 M | 926 M | 1.23 B | 852 M | 926 M | 1.23 B | 1.68 B | 1.63 B | 1.57 B | 1.55 B | 1.64 B | 1.59 B | 1.5 B | 1.51 B | 1.49 B | 1.46 B | 1.4 B | 1.36 B | 1.33 B | 1.35 B | 1.27 B | 1.2 B | 1.2 B | 1.21 B | 1.21 B | 1.31 B | 1.22 B | 1.16 B | 1.16 B | 1.09 B | 1.04 B | 1.03 B | 1.03 B | 1.08 B | 1.01 B | 984 M | 1.04 B | 1.02 B | 1.02 B | 980 M | 992 M | 956 M | 930 M | 968 M | 911 M | 932 M | 905 M | 859 M | 802 M | 780 M | 1.03 B | 1.01 B | 971 M | 944 M | 927 M | 890 M | 852 M | 827 M | 797 M | 764 M | 726 M | - | 686 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Helen of Troy Limited, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Household products
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Colgate-Palmolive Company
CL
|
$ 88.5 | 1.96 % | $ 71.6 B |  USA |
 |
The Clorox Company
CLX
|
$ 89.57 | 2.06 % | $ 11.1 B | USA |
 |
Coty
COTY
|
$ 2.71 | 0.19 % | $ 2.38 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.92 | 0.77 % | $ 12.3 M |  China |
 |
The Estée Lauder Companies
EL
|
$ 98.58 | 1.5 % | $ 35.7 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 97.02 | 0.11 % | $ 5.65 B | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 27.03 | 0.37 % | $ 1.28 B | USA |
 |
Acme United Corporation
ACU
|
$ 60.89 | 0.28 % | $ 231 M | USA |
 |
Inter Parfums
IPAR
|
$ 112.19 | 0.16 % | $ 3.6 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 100.06 | 1.95 % | $ 33.2 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 6.16 | 0.81 % | $ 77.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.01 | 1.04 % | $ 15.2 M | USA |
 |
Nature's Sunshine Products
NATR
|
$ 13.41 | 0.89 % | $ 241 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.83 | 0.1 % | $ 238 M | USA |
 |
Newell Brands
NWL
|
$ 5.84 | 0.43 % | $ 2.44 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 146.29 | 0.7 % | $ 341 B | USA |
 |
Spectrum Brands Holdings
SPB
|
$ 85.06 | 0.6 % | $ 2.19 B | USA |
 |
United-Guardian
UG
|
$ 7.18 | 0.07 % | $ 33 M | USA |
 |
Unilever PLC
UL
|
$ 63.8 | 2.87 % | $ 139 B |  Britain |
 |
USANA Health Sciences
USNA
|
$ 15.15 | 0.87 % | $ 281 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 95.16 | 1.07 % | $ 23.1 B | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Hims & Hers Health
HIMS
|
$ 29.3 | 6.51 % | $ 6.59 B | USA |